Delayed diagnosis of fibrinogen Aα-chain amyloidosis after dual heart-kidney transplantation

Transplant International

Volumn 26, Issue 1, 2013, Pages

  Legris, Tristan ^a,b   Daniel, Laurent ^a,c   Moal, Valérie ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A; FIBRINOGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITAZOXANIDE; PREDNISONE; THYMOCYTE ANTIBODY;

ACUTE DIARRHEA; ALBUMINURIA; AMYLOIDOSIS; ANGIOCARDIOGRAPHY; ATRIOVENTRICULAR BLOCK; CARDIAC GRAFT REJECTION; CORONARY ARTERY OBSTRUCTION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CRYPTOSPORIDIOSIS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FIBRINOGEN ALPHA CHAIN AMYLOIDOSIS; FRAMESHIFT MUTATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HEMODIALYSIS; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LETTER; PACEMAKER; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROTEINURIA; PULMONARY ARTERY OCCLUSION PRESSURE;

AMYLOIDOSIS; DELAYED DIAGNOSIS; FIBRINOGEN; HEART TRANSPLANTATION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 84871303518     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12002     Document Type: Letter

References (10)

1. Lachmann HJ, Booth DR, Booth SE, etal. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 2002; 346: 1786.
2. Gillmore JD, Lachmann HJ, Rowczenio D, etal. Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen Aalpha-chain amyloidosis. J Am Soc Nephrol 2009; 20: 444.
3. Mousson C, Heyd B, Justrabo E, etal. Successful hepatorenal transplantation in hereditary amyloidosis caused by a frame-shift mutation in fibrinogen Aalpha-chain gene. Am J Transplant 2006; 6: 632.
4. Stangou AJ, Banner NR, Hendry BM, etal. Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood 2010; 115: 2998.
5. Gillmore JD, Lachmann HJ, Wechalekar A, Hawkins PN,. Hereditary fibrinogen A alpha-chain amyloidosis: clinical phenotype and role of liver transplantation. Blood 2010; 115: 4313; author reply 4-5.
6. Benson MD, Liepnieks J, Uemichi T, Wheeler G, Correa R,. Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain. Nat Genet 1993; 3: 252.
7. Sethi S, Fervenza FC, Miller D, Norby S, Leung N,. Recurrence of amyloidosis in a kidney transplant. Am J Kidney Dis 2010; 56: 394.
8. Zeldenrust S, Gertz M, Uemichi T, etal. Orthotopic liver transplantation for hereditary fibrinogen amyloidosis. Transplantation 2003; 75: 560.
9. Gillmore JD, Booth DR, Rela M, etal. Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen alpha-chain variant in an English family. QJM 2000; 93: 269.
10. Raichlin E, Daly RC, Rosen CB, etal. Combined heart and liver transplantation: a single-center experience. Transplantation 2009; 88: 219.